Henney highlights priorities for cash-strapped FDA as she embraces the letter and spirit of the law
This article was originally published in Clinica
Executive Summary
The FDA's new commissioner, Jane Henney, said in her first major public speech in the US last week that she would focus on five top priorities: blood safety; tobacco regulation; food safety; implementation of the FDA Modernization Act of 1997(FDAMA); and promoting the agency's scientific base. In her brief remarks at the Food and Drug Law Institute's annual meeting she made no mention of the medical device industry.